Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for THIOMAB™ Drug Conjugates
Siddharth Sukumaran(Johnson & Johnson (United States)), Kedan Lin(University of Delaware), Luna Liu(Snap (United States)), Shang‐Fan Yu(Genesys (United States)), Keyang Xu(Macau University of Science and Technology), Elaine Mai(Snap (United States)), Jagath R. Junutula(Chrono Therapeutics (United States)), Katherine R. Kozak(University of California, Los Angeles), Crystal Zhang, Sunil Bhakta(Intarcia Therapeutics (United States)), Kapil Gadkar(Sea Turtle Conservancy), Aimee Fourie-O’Donohue, Saroja Ramanujan(Unknown), Helga Raab
Cited by 43
Related Papers
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
|Nature Biotechnology|2008|1.4k
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
|Nature Biotechnology|2012|997
Characterization of the Role of the Rab GTPase-activating Protein AS160 in Insulin-regulated GLUT4 Trafficking
|Journal of Biological Chemistry|2005|392